Continued elucidation of mechanisms by which HDAC7 contributes to dysregulated homeostasis will undoubtedly deliver further molecular insights into a range of cancers, inflammatory diseases and metabolic disorders and may ultimately validate HDAC7 as a target in one or more of these conditions. This evidence concerns the gene HDAC7 and Other metabolic disease.